Abstract The PI3K/Akt pathway is an actively pursued therapeutic target in oncology. In
prostate cancer, the activation of this pathway appears to be characteristic of many …

Tyr phosphatases are, by definition, enzymes that dephosphorylate phospho‐Tyr (pT yr)
from proteins. This activity is found in several structurally diverse protein families, including …

Systems and methods are disclosed for communicating data in an integrated sensor network
having one or more nodes coupled to an optical sensor network and a radio frequency …

Recent immunotherapy research has focused on chimeric antigen receptor-modified T cells
(CAR-Ts). CAR-T therapies have been clinically applied to manage hematologic …

Prostate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In
contrast to the situation in humans, multi-gene approaches facilitating risk stratification of …

Abstract Bisperoxovanadium (pyridine-2-carboxyl)[bpV (pic)] is a commercially available
PTEN inhibitor. Previous studies from us and others have shown that bpV (pic) confers …

Prostate cancer (PCa) is the second most frequent type of cancer in men and assessing
circulating tumor cells (CTCs) by liquid biopsy is a promising tool to help in cancer early …

Prostate-specific antigen (PSA) is a well-known clinical biomarker in prostate cancer (PCa)
diagnosis, but a better test is still needed, as the serum-level-based PSA quantification …

Clinical management of prostate cancer remains a significant challenge due to the lack of
available tests for guiding treatment decisions. The blood prostate‐specific antigen test has …

High mobility group box 1 (HMGB1) is an ubiquitous protein that plays different roles in the
nucleus, cytoplasm, and extracellular space. It is an important DAMP molecule that allows …